Acquisition Announced
Olympus acquisition of BioProtect
US$270m consideration
Announced May 2026 (approx.)
Advisers
Olympus
Acquirer
Not disclosed
- Target
- BioProtect
- Acquirer
- Olympus
- Target based in
- Israel
- Buyer based in
- Japan
- Sector
- Medtech
- Tags
- Medtech, Oncology
Similar deals
- Merit Medical Systems acquisition of View Point Medical Apr 2026 · US$140m · Medtech
- iRhythm Holdings acquisition of Vital Connect Aug 2026 · US$288m · Medtech
- iRhythm Holdings acquisition of VitalConnect Aug 2026 · US$288m · Medtech
- Smith+Nephew acquisition of Integrity Orthopaedics Jan 2026 · US$225m · Medtech
- Eli Lilly and Company acquisition of CrossBridge Bio Apr 2026 · US$300m · Biotech
Sources
- May 2026 Guggenheim Securities: Exclusive Financial Advisor to BioProtect on its Sale to Olympus guggenheimsecurities.com